The cutaneous assessment tool: Development and reliability in juvenile idiopathic inflammatory myopathy

Rheumatology

Volumn 46, Issue 10, 2007, Pages 1606-1611

  Huber, Adam M ^a   Dugan, E M ^b   Lachenbruch, P A ^c,n   Feldman, B M ^d   Perez, M D ^e   Zemel, L S ^f   Lindsley, C B ^g   Rennebohm, R M ^h   Wallace, C A ⁱ   Passo, M H ^j   Reed, A M ^k   Bowyer, S L ^l   Ballinger, S H ^l   Miller, F W ^m   Rider, L G ^m   Colbert, Robert ^o   DeInocencio, Jaime ^o   Griffin, Thomas ^o   Hashkes, Philip ^o   Hirsch, Raphael ^o   Kredich, Deborah ^o   Laxer, Ronald ^o   Levinson, Joseph ^o   Lovell, Daniel ^o   Ruperto, Nicola ^o   Silverman, Earl ^o   Sundel, Robert ^o   Vogelgesang, Scott ^o   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CONNECTICUT   (United States)

^g UNIVERSITY OF KANSAS   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

^k MAYO CLINIC   (United States)

^l INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

ⁿ OREGON STATE UNIVERSITY   (United States)

^o NONE

more..

Author keywords

Assessment; Cutaneous Assessment Tool; Juvenile dermatomyositis; Juvenile idiopathic inflammatory myopathy; Skin disease

Indexed keywords

ARTICLE; CHILD; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CUTANEOUS ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FACE ERYTHEMA; HUMAN; INTERRATER RELIABILITY; JUVENILE IDIOPATHIC MYOSITIS; MAJOR CLINICAL STUDY; MYOSITIS; PAPULE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RASH; SCORING SYSTEM; SKIN DEFECT; SKIN EXAMINATION;

CHILD; DERMATOMYOSITIS; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 34848821968     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem179     Document Type: Article

References (17)

1. Callen JP. Dermatomyositis. Lancet 2000;355:53-7.
2. Santmyire-Rosenberger B, Dugan EM. Skin involvement in dermatomyositis. Curr Opinion Rheumatol 2003;15:714-22.
3. Sontheimer RD. Skin manifestations of systemic autoimmune connective tissue disease: Diagnostics and therapeutics. Best Pract Res Clin Rheumatol 2004;18:429-62.
4. Huber AM, Feldman BM, Rennebohm RM et al. Validation and Clinical Significance of the Childhood Myositis Assessment Scale (CMAS) for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595-603.
5. Huber AM, Hicks JE, Lachenbruch PA et al. Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic inflammatory myopathies. J Rheumatol 2001;28:1106-11.
6. Smith R, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol 2004;31:1644-9.
7. Huber AM, Lang B, LeBlanc CM et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2001;43:541-9.
8. Miller FM, Rider LG, Chung Y et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathy. Rheumatology 2001;40:1262-73.
9. Ruperto N, Ravelli A, Murray K et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003;42:1452-9.
10. Frederiksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238.
11. Feldman SR, Fleischer AB, Reboussin DM et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106:183-6.
12. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence. Arthritis Care Res 2003;49:7-15.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975;292:344-7.
14. Rider LG, Feldman BM, Perez MD et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, Parent and Patient Global Assessments. Arthritis Rheum 1997;40:1976-83.
15. Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psych Bull 1979;86:420-8.
16. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 3rd edn. New York: Oxford University Press, 2003.
17. Jain M, Smith M, Cintas H et al. Intra-rater and inter-rater reliability of the 10-point manual muscle test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM). Phys Occup Ther Pediatr 2006;26:5-17.